William Pao
Directeur/Bestuurslid bij Transcelerate Biopharma, Inc.
Vermogen: 3 M $ op 31-05-2024
Actieve functies van William Pao
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Directeur/Bestuurslid | - | - |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Directeur/Bestuurslid | - | - |
Loopbaan van William Pao
Eerdere bekende functies van William Pao
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 21-03-2022 | 15-08-2023 |
ROCHE HOLDING AG | Corporate Officer/Principal | 01-05-2014 | 18-03-2022 |
My Cancer Genome | Oprichter | - | - |
The Vanderbilt-Ingram Cancer Center
The Vanderbilt-Ingram Cancer Center Hospital/Nursing ManagementHealth Services The Vanderbilt-Ingram Cancer Center engages in the prevention, diagnosis, and treatment of cancer. The non-profit company is based in Nashville, TN. | Corporate Officer/Principal | - | - |
Vanderbilt University | Corporate Officer/Principal | - | - |
Opleiding van William Pao
Harvard University | Undergraduate Degree |
Yale University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 10 |
Operationeel
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PFIZER, INC. | Health Technology |
ROCHE HOLDING AG | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
The Vanderbilt-Ingram Cancer Center
The Vanderbilt-Ingram Cancer Center Hospital/Nursing ManagementHealth Services The Vanderbilt-Ingram Cancer Center engages in the prevention, diagnosis, and treatment of cancer. The non-profit company is based in Nashville, TN. | Health Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
My Cancer Genome |
- Beurs
- Insiders
- William Pao
- Ervaring